Health Condition 1: L22- Diaper dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Infants who suffers with Ahiputana 2.Infants age upto 1 year. 3.Patients will be selected irrespective of sex and socioeconomic status. 4.The patients whose parents are ready to participate in the clinical trial by giving informed written consent.
Exclusion criteria
Exclusion criteria: 1.Infants having other generalized skin infections. 2.Infants having life threatening illness. 3.Infants who are known cases of systemic illness. 4.Infants who have other than clinical signs and symptoms of AHIPUTANA. 5.Children Above 1 Year of age. 6.History of Ahiputana more than 10 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will see the effect of interventional drug on the skin rash and itching Of AHIPUTANA Are Expected To Be Reduced After The Use Of Asana Malahara In Infants Timepoint: We will see the effect of interventional drug on the skin rash and itching Of AHIPUTANA Are Expected To Be Reduced After The Use Of Asana Malahara In Infants | — |
Secondary
| Measure | Time frame |
|---|---|
| The Symptoms Like Kandu And Pidika Are Expected To Be Relieved Maximum And Other Symptoms Had Moderate Relief And Also There Will Be Minimum Adverse Effects Timepoint: 5 days study with follow up on 3rd and 5th day (0,3,5 days) | — |
Countries
India
Contacts
Dr. D. Y. Patil College of Ayurved and Research Centre